Regen BioPharma Inc (RGBP): RGBP could possibly be sitting on signif...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	36
Posts	1166
Boards Moderated	0
Alias Born	03/07/2013

cvinvestor

Re: None

Thursday, 06/23/2016 5:46:32 PM

Thursday, June 23, 2016 5:46:32 PM

RGBP could possibly be sitting on significant news for a variety of things:

- results of Dr. Kesari's experiments for dCellVax which were to be used in responding to FDA questions on IND within Q2 of 2016

- 3 month results for HemaXellerate trials going on in Mexico

- Orphan Drug Status application results for HemaXellerate filed in Jan 2016

- IND response for tCellVax checkpoint inhibitor filed March 23, 2016 using siRNA silenced NR2F6

- results of experiments for ucVax that began in May 2016

PRs over last couple of months have pointed out new things and given us news on specific positive developments, but have not addressed some of the older outstanding issues and filings. Obviously, a lot more has happened behind the scenes than we are aware of. Hopefully, most of it will turn out to be good news. Would be nice to have a follow up on Dr. Kesari, dCellVax and whether he plans on development of dCellVax IND for gliomas as previously indicated as a possibility.